注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Purple Biotech Ltd(原名:Kitov Pharma Ltd)是一家以色列的臨床階段公司,致力於開發克服腫瘤免疫逃逸和耐藥性疼痛的藥物。該公司的主要產品是NT-219 i CM-24。CM-24是一種單克隆抗體阻斷素,而NT-219是一種具有兩種主要抗癌途徑的小分子雙特異性抑制劑。該公司還是塞來昔布和苯磺酸氨氯地平的固定劑量組合Consensi的所有者,用於同時治療骨關節炎疼痛和高血壓。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Eric K. Rowinsky | 65 | 2019 | Independent Chairman of the Board |
Sunil Sharma | - | 2023 | Member of Scientific Advisory Board |
Robert E. Gagnon | 49 | 2021 | Independent Director |
Ori Hershkovitz | 48 | 2021 | Independent Director |
Steven Maron | - | 2023 | Member of Scientific Advisory Board |
Scott Faucett | - | 2014 | Member of Scientific Advisory Board |
Sean Welton | - | 2014 | Member of Scientific Advisory Board |
Suzana Nahum-Zilberberg | 52 | 2021 | Independent Director |
Eyal Gottlieb | - | 2023 | Member of Scientific Advisory Board |
Yael Margolin | 70 | 2023 | Independent Director |
Simcha Rock | 74 | 2013 | Independent Director |
Ido Agmon | 47 | 2016 | Independent Director |
Isaac Israel | 46 | 2012 | Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核